Back to Newsroom

Curis Announces Effectiveness of 1-for-5 Reverse Stock Split

LEXINGTON, Mass.May 29, 2018 /PRNewswire/ — Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today announced that its previously disclosed 1-for-5 reverse stock split will be effective as of 5:00 p.m. Eastern Time today, May 29, 2018.  Curis’s common stock will begin trading on the Nasdaq Global Market on a split-adjusted basis when the market opens on Wednesday, May 30, 2018.  The new CUSIP number for Curis’s common stock following the reverse stock split is 231269 200.